It was reported that approximately six minutes into the treatment with a polyflux 14l, the patient experienced headache, lumbago, palpitation, and sweating.The patient was administered 300ml intravenous infusion of 0.9% sodium chloride injection, oxygen inhalation and 10 mg dexamethasone (intravenous) for the events.The set was replaced, and treatment was restarted ten minutes later with no further patient symptoms.No additional information is available.
|
A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The device was not received for evaluation; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
|